NCT04526379

Brief Summary

The present project project is divided in two parts. The primary aim of the part 1 of this study is to evaluate emotional control abilities of children with Prader-Willi syndrome (PWS) aged from 9 to 15 years and to study repercussions of this supposed lack of abilities on cognitive capacities and behavioral troubles. The study also evaluate influence of the emotional symptomatology of patients on quality of parents' life and on the care of parents and scholar/institutional caregivers. In the second part of this study, the study evaluate the feasibility and the tolerance to a non-invasive device supposed to reduce emotional symptoms in this disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 3, 2020

Completed
6 months until next milestone

First Posted

Study publicly available on registry

August 25, 2020

Completed
13 days until next milestone

Study Start

First participant enrolled

September 7, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 7, 2020

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 27, 2022

Completed
Last Updated

August 23, 2023

Status Verified

August 1, 2023

Enrollment Period

3 months

First QC Date

March 3, 2020

Last Update Submit

August 22, 2023

Conditions

Keywords

EmotionCognition

Outcome Measures

Primary Outcomes (1)

  • assessment of the level of emotional control

    composite score of emotional control level of children with PWS composed of scores of emotional lability

    day 0

Secondary Outcomes (5)

  • Evaluation of behavioral disorders of children with PWS by CBCL (Child Behavior Checklist) scale

    month 6

  • Evaluation of behavioral disorders of children with PWS by Hyperphagia Questionnaire

    month 6

  • Evaluation of cognitive abilities of children with PWS

    2 days

  • Test of evaluation of cognitive abilities

    2 days

  • Evaluation of cognitive abilities

    2 days

Study Arms (2)

children with PWS

EXPERIMENTAL

Evaluation of cognitive abilities of children with PWS by several cognitive tasks and neuropsychological tests.

Behavioral: QuestionnairesDevice: t-VNS

non affected children

OTHER

Evaluation of cognitive abilities of children with PWS compared to a non-pathologic population of children by several cognitive tasks and neuropsychological tests

Behavioral: Questionnaires

Interventions

QuestionnairesBEHAVIORAL

Evaluation of behavioral disorders of children with PWS by questionnaires

children with PWSnon affected children
t-VNSDEVICE

Evaluation of the influence of 6 month-stimulation by t-VNS on emotional, cognitive, and behavioral/clinical characteristics of 12 children with PWS on 30 PWS patients included.

children with PWS

Eligibility Criteria

Age9 Years - 15 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age from 9 to 15 years old
  • Prader-Willi syndrome with identified genotype.
  • No psychiatric disorder neither PWS.
  • Severe global symptomatology attested by a CGI-S score

You may not qualify if:

  • Identified psychiatric or behavioral disorders
  • Severe visual or hearing impairment.
  • Sleep apnea syndrome treated with non-invasive ventilation,
  • Epileptic seizures
  • Cardiac disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital

Toulouse, France

Location

MeSH Terms

Conditions

Prader-Willi Syndrome

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Intellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesChromosome DisordersGenetic Diseases, InbornImprinting DisordersObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Maithé TAUBER, MD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: The study consists of 2 parts. The first part compares 30 children with PWS compared to 30 control children without PWS. The second part will be based on 12 children with PWS who have undergone part 1.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 3, 2020

First Posted

August 25, 2020

Study Start

September 7, 2020

Primary Completion

December 7, 2020

Study Completion

April 27, 2022

Last Updated

August 23, 2023

Record last verified: 2023-08

Locations